FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ribavirin by Aurobindo Pharma Limited (ANDA 079111).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection
• Viral Hepatitis

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

SUPPL AP for RIBAVIRIN (RIBAVIRIN)